Research Using the NACC Database


Transitions and pharmaceutical use by CDR level in Alzheimers disease.

 
   Lead Investigator:    Eldon Spackman
   Institution      :    University of Washington
   E-Mail           :    spackman@u.washington.edu
   Proposal ID      :    78

Publications:
1 Bloudek L, Spackman E, Sullivan SD A Comparison of Transitions between Health States and Institutionalization among AD Patients vs Non-AD Dementia Patients Using the NACC-UDS Database Abstract Value Health,13:A108-A109,2010,
PUBLISHED

2 Bloudek LM, Spackman DE, Veenstra DL, Sullivan SD CDR State Transition Probabilities in Alzheimer's Disease with an without Cholinesterase Inhibitor Intervention in an Observational Cohort Journal Article J Alzheimers Dis,24:599-607,2011,PMC3593724
PUBLISHED

3 Spackman DE, Kadiyala S, Neumann PJ, Veenstra DL, Sullivan SD Measuring Alzheimer disease progression with transition probabilities: Estimates from NACC-UDS Journal Article Curr Alzheimer Res,9:1050-1058,2012,PMC3690579
PUBLISHED

Proposal Description:
  • rss icon
  • twitter icon
  • facebook icon

NACC is funded by the National Institute on Aging (UO1 AG016976) and located in the Department of Epidemiology at the University of Washington School of Public Health, Walter A. Kukull, Ph.D., Director. Copyright© 2010 University of Washington.